Case by Case: Reviewing Diagnois and Treatment of Chronic Progressive Fibrosing Interstitial Lung Disease Case of Rheumatoid Arthritis Arthritis-Associated Interstitial Lung Disease

CME: 0.50

Target Audience

This activity has been designed to meet the educational needs of pulmonologists, radiologists, and pathologists. It may also be of benefit to primary care physicians, rheumatologists, PAs, nurse practitioners, nurses, pharmacists, fellows, residents, and other healthcare professionals who care for patients with chronic progressive fibrosing interstitial lung disease (PF-ILD).

Program Overview

Progressive fibrosing ILD occurring in patients with RA significantly increases mortality risk. Anti-inflammatory and antifibrotic agents may be used to treat RA-ILD.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Analyze laboratory and imaging data to diagnose PF-ILD
  • Evaluate patient risk factors for PF-ILD
  • Develop appropriate, evidence-based treatment plans for patients who have PF-ILD
  • Formulate a communication plan for patients with PF-ILD to provide education about the disease and treatment

Post a comment to this article